Microbot Medical
MBOT
71 hedge funds and large institutions have $22.1M invested in Microbot Medical in 2026 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 13 reducing their positions, and 17 closing their positions.
85% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 13
47% more call options, than puts
Call options by funds: $722K | Put options by funds: $491K
4.32% less ownership
Funds ownership: 21.2% → 16.88% (-4.3%)
10% less funds holding
Funds holding: 79 → 71 (-8)
35% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 17
36% less capital invested
Capital invested by funds: $34.3M → $22.1M (-$12.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mitsubishi UFJ Asset Management
Tokyo,
Japan
|
+$2.59M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
+$165K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$154K |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$124K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$122K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CBU
CIBC Bancorp USA
Chicago,
Illinois
|
-$4.51M |
| 2 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$1.15M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$812K |
| 4 |
Millennium Management
New York
|
-$751K |
| 5 |
Goldman Sachs
New York
|
-$745K |
MBOT Hedge Fund Activity: Q2 2026 in Review
71 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q2 2026, worth a combined $22.1M — down 36% from $34.3M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of MBOT and 11 opened new positions — a net loss of 6 holders — while 13 trimmed existing stakes and 24 added.
The largest buyer was Mitsubishi UFJ Asset Management, opening a new position worth an estimated $2.59M. The largest seller was CIBC Bancorp USA, exiting entirely with an estimated $4.51M sold.
- 71 institutional investors held Microbot Medical (MBOT) as of Q2 2026, down from 79 in Q1 2026.
- Funds reported $22.1M of Microbot Medical stock for Q2 2026, down 36% quarter-over-quarter.
- 11 funds opened new Microbot Medical positions in Q2 2026 and 17 closed out, a net change of -6 holders.
- The largest Microbot Medical buyer in Q2 2026 was Mitsubishi UFJ Asset Management, an estimated $2.59M added.
- The largest Microbot Medical seller in Q2 2026 was CIBC Bancorp USA, an estimated $4.51M sold.
Based on aggregated 13F filings for Q2 2026.